Mar 27, 2023
Suraj Mudichintala is a Senior Associate at Action Potential Capital which is GSK's bioelectronic medicine venture fund.
Top 3 Takeaways:
Mar 20, 2023
Balint Varkuti is the CEO of CereGate which unlocks new capabilities for existing neuromodulation technologies using software.
Top 3 Takeaways:
Mar 13, 2023
Kevin Tracey returns to the podcast to give an update about his work at the Feinstein Institutes and the work at SetPoint Medical.
Top 3 Takeaways:
Mar 6, 2023
Israel Gasperin is the founder and CEO of Zentrela which uses wearable EEG caps to quantitatively measure cannabis experiences.
Top 3 Takeaways:
Feb 13, 2023
Colin Kealey is the President and CEO of NeuroSigma which is commercializing the Monarch eTNS System, the first non-drug treatment for pediatric ADHD cleared by the FDA.
Top 3 Takeaways: